UPDATED: FDA warnings slam Chinese drugmakers, including ViiV partner

Wednesday, June 29, 2016

The FDA has been closely scrutinizing Chinese production facilities, and now two Chinese companies with ties to Western drugmakers have been called on the mat to account for problems in their manufacturing. The FDA has issued warning letters to plants operated by Shanghai Desano Chemical Pharmaceutical and Chongqing Lummy Pharmaceutical, slamming them both for manipulating testing and turning in falsified batch test results on APIs. Read more fromFiercePharmaManufacturing